An Open Label, Non Randomised, Phase II study to Determine if Dabigatran and its Metabolites are Detectable in Breast Milk Following Oral Administration to Non- Breastfeeding Mothers

Trial Profile

An Open Label, Non Randomised, Phase II study to Determine if Dabigatran and its Metabolites are Detectable in Breast Milk Following Oral Administration to Non- Breastfeeding Mothers

Completed
Phase of Trial: Phase II

Latest Information Update: 14 Sep 2016

At a glance

  • Drugs Dabigatran etexilate (Primary)
  • Indications Deep vein thrombosis
  • Focus Pharmacokinetics
  • Acronyms DALMATION
  • Most Recent Events

    • 19 Feb 2016 Status changed from not yet recruiting to recruiting, according to United Kingdom Clinical Research Network record.
    • 16 Dec 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top